Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2006 1
2010 2
2011 2
2012 5
2013 6
2014 6
2015 4
2016 3
2017 6
2018 6
2019 5
2020 4
2021 9
2022 5
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Selecting the optimal radiation modality in prostate cancer.
Valle LF, Kishan AU, Franco A, Ma TM, Nikitas J, Farrell M, Chang AJ, Nickols NG, Steinberg ML. Valle LF, et al. Among authors: chang aj. Clin Adv Hematol Oncol. 2023 Sep;21(9):494-501. Clin Adv Hematol Oncol. 2023. PMID: 37647496 Review.
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.
Corkum MT, Buyyounouski MK, Chang AJ, Chung HT, Chung P, Cox BW, Crook JM, Davis BJ, Frank SJ, Henriquez I, Horwitz EM, Hoskin P, Hsu IC, Keyes M, King MT, Kollmeier MA, Krauss DJ, Kukielka AM, Morton G, Orio PF 3rd, Pieters BR, Potters L, Rossi PJ, Showalter TN, Solanki AA, Song D, Vanneste B, Vigneault E, Wojcieszek PA, Zelefsky MJ, Kamrava M. Corkum MT, et al. Among authors: chang aj. Radiother Oncol. 2023 Jul;184:109672. doi: 10.1016/j.radonc.2023.109672. Epub 2023 Apr 13. Radiother Oncol. 2023. PMID: 37059334
Multimodality Therapies for Localized Prostate Cancer.
Valle LF, Jiang T, Weiner AB, Reiter RE, Rettig MB, Shen J, Chang AJ, Nickols NG, Steinberg ML, Kishan AU. Valle LF, et al. Among authors: chang aj. Curr Oncol Rep. 2023 Mar;25(3):221-229. doi: 10.1007/s11912-023-01374-9. Epub 2023 Feb 1. Curr Oncol Rep. 2023. PMID: 36723856 Review.
Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial.
Shee K, de la Calle CM, Chang AJ, Wong AC, Feng FY, Gottschalk AR, Carroll PR, Nguyen HG. Shee K, et al. Among authors: chang aj. Adv Radiat Oncol. 2022 Mar 12;7(5):100941. doi: 10.1016/j.adro.2022.100941. eCollection 2022 Sep-Oct. Adv Radiat Oncol. 2022. PMID: 35847550 Free PMC article.
61 results